Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice-Reference-Cited by-同舟云学术

Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice

Published:2012-09-30 Issue:1 Volume:28 Page:55-62
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Takamiya Yoshimi,Fukami Kei,Yamagishi Sho-ichi,Kaida Yusuke,Nakayama Yosuke,Obara Nana,Iwatani Ryuji,Ando Ryotaro,Koike Kiyomi,Matsui Takanori,Nishino Yuri,Ueda Seiji,Cooper Mark E.,Okuda Seiya

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/28/1/55/13493813/gfs387.pdf

Reference21 articles.

1. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study;Maisonneuve;Am J Kidney Dis,2000

2. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?;Gilbert;Kidney Int,1999

3. Renal structure and function in insulin-dependent diabetes mellitus and type I membranoproliferative glomerulonephritis in humans;Mauer;J Am Soc Nephrol,1992

4. Reactive oxygen species and matrix remodeling in diabetic kidney;Ha;J Am Soc Nephrol,2003

5. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy;Han;Nephrol Dial Transplant,2006

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matrix Metalloproteinase 2 Is Crucial for Hypertension- and Hyperglycemia-Induced Kidney Injury Independent of Blood Pressure;Journal of Cardiovascular Pharmacology;2023-12

2. Knockout of Matrix Metalloproteinase 2 Opposes Hypertension- and Diabetes-induced Nephropathy;Journal of Cardiovascular Pharmacology;2023-11-30

3. Identification of Fibrotic Biomarkers Associated with Macrophages in Diabetic Nephropathy;Medical Science Monitor;2023-09-26

4. Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation;Journal of Translational Medicine;2023-06-12

5. Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway;Acta Pharmacologica Sinica;2023-05-24